Recently VEGF - B and VEGF - C, two new VEGF family members, have been identified that bind to the tyrosine kinase receptors flt - 1 ( VEGFR1), KDR ( VEGFR2), and flt - 4 ( VEGFR3).	"VEGF - B	9	17	Gene_or_gene_product"	"VEGF - C	22	30	Gene_or_gene_product"	"VEGF	40	44	Gene_or_gene_product"	"flt - 1	125	132	Gene_or_gene_product"	"VEGFR1	135	141	Gene_or_gene_product"	"KDR	144	147	Gene_or_gene_product"	"VEGFR2	150	156	Gene_or_gene_product"	"flt - 4	163	170	Gene_or_gene_product"	"VEGFR3	173	179	Gene_or_gene_product"	"[{""token"": ""VEGF - B"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 1"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR1"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 4"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR3"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}]"
Hck - mediated cellular transformation of murine fibroblasts is reverted by ectopic expression of a membrane - anchored allele of Cbl as assessed by the cellular morphology, suppression of anchorage independent growth, and an overall reduction in the total tyrosine phosphorylation levels within the cells.	"Hck	0	3	Gene_or_gene_product"	"cellular	15	23	Cell"	"murine	42	48	Organism"	"fibroblasts	49	60	Cell"	"membrane	100	108	Cellular_component"	"Cbl	130	133	Gene_or_gene_product"	"cellular	153	161	Cell"	"tyrosine	257	265	Amino_acid"	"cells	300	305	Cell"	"[{""token"": ""Hck"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""murine"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""membrane"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Cellular_component""}, {""token"": ""Cbl"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""tyrosine"", ""start_span"": 257, ""end_span"": 265, ""type"": ""Amino_acid""}, {""token"": ""cells"", ""start_span"": 300, ""end_span"": 305, ""type"": ""Cell""}]"
By using immunohistochemistry, Western blot, and real - time PCR the expression patterns of TSP - 1, TSP - 2, CD36, CD47, MMP - 2, and MMP - 9 were investigated in normal rat prostate tissue and five malignant Dunning sublines tissue.	"TSP - 1	92	99	Gene_or_gene_product"	"TSP - 2	101	108	Gene_or_gene_product"	"CD36	110	114	Gene_or_gene_product"	"CD47	116	120	Gene_or_gene_product"	"MMP - 2	122	129	Gene_or_gene_product"	"MMP - 9	135	142	Gene_or_gene_product"	"rat	171	174	Organism"	"prostate tissue	175	190	Tissue"	"malignant Dunning sublines tissue	200	233	Tissue"	"[{""token"": ""TSP - 1"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 2"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD36"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD47"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Organism""}, {""token"": ""prostate tissue"", ""start_span"": 175, ""end_span"": 190, ""type"": ""Tissue""}, {""token"": ""malignant Dunning sublines tissue"", ""start_span"": 200, ""end_span"": 233, ""type"": ""Tissue""}]"
Additionally, knockdown of p600 reduced transformation of cells expressing both BPV - 1 E6 and E7, as well as E6 alone, suggesting that the ability of E7 to transformed cells is mediated, at least in part, through its ability to bind p600.	"p600	27	31	Gene_or_gene_product"	"cells	58	63	Cell"	"BPV - 1	80	87	Organism"	"E6	88	90	Gene_or_gene_product"	"E7	95	97	Gene_or_gene_product"	"E6	110	112	Gene_or_gene_product"	"E7	151	153	Gene_or_gene_product"	"cells	169	174	Cell"	"p600	234	238	Gene_or_gene_product"	"[{""token"": ""p600"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""BPV - 1"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""E6"", ""start_span"": 88, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 95, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 151, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Cell""}, {""token"": ""p600"", ""start_span"": 234, ""end_span"": 238, ""type"": ""Gene_or_gene_product""}]"
Brain pericytes in culture had higher levels of endosialin / TEM 1 than TEMs - 2, - 3, - 4, - 5, - 7, and - 8.	"Brain pericytes	0	15	Cell"	"endosialin	48	58	Gene_or_gene_product"	"TEM 1	61	66	Gene_or_gene_product"	"TEMs - 2	72	80	Gene_or_gene_product"	"- 3	82	85	Gene_or_gene_product"	"- 4	87	90	Gene_or_gene_product"	"- 5	92	95	Gene_or_gene_product"	"- 7	97	100	Gene_or_gene_product"	"- 8	106	109	Gene_or_gene_product"	"[{""token"": ""Brain pericytes"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""endosialin"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEM 1"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEMs - 2"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 3"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 4"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 5"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 7"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 8"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"
Here, in order to characterize the role of the promoter that drives DSCR - 1s expression in mediating inducible expression in vivo and to determine the functional relevance of DSCR - 1s in inflammation, we targeted a DNA construct containing 1. 7 kb of the human DSCR1s promoter coupled to the lacZ reporter to the hypoxanthine guanine phosphoribosyl transferase ( Hprt) locus of mice.	"DSCR - 1s	68	77	Gene_or_gene_product"	"DSCR - 1s	176	185	Gene_or_gene_product"	"DNA	217	220	Cellular_component"	"human	257	262	Organism"	"DSCR1s	263	269	Gene_or_gene_product"	"lacZ	294	298	Gene_or_gene_product"	"hypoxanthine guanine phosphoribosyl transferase	315	362	Gene_or_gene_product"	"Hprt	365	369	Gene_or_gene_product"	"mice	380	384	Organism"	"[{""token"": ""DSCR - 1s"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1s"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 257, ""end_span"": 262, ""type"": ""Organism""}, {""token"": ""DSCR1s"", ""start_span"": 263, ""end_span"": 269, ""type"": ""Gene_or_gene_product""}, {""token"": ""lacZ"", ""start_span"": 294, ""end_span"": 298, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxanthine guanine phosphoribosyl transferase"", ""start_span"": 315, ""end_span"": 362, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hprt"", ""start_span"": 365, ""end_span"": 369, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 380, ""end_span"": 384, ""type"": ""Organism""}]"
Ploidy analysis was carried out on 39 EOGCs and immunohistochemistry of CDC4 / FBXW7 and its substrates c - myc, c - jun, Notch and cyclin E was performed on 204 gastric carcinomas using tissue microarrays ( TMAs).	"EOGCs	38	43	Cancer"	"CDC4	72	76	Gene_or_gene_product"	"FBXW7	79	84	Gene_or_gene_product"	"c - myc	104	111	Gene_or_gene_product"	"c - jun	113	120	Gene_or_gene_product"	"Notch	122	127	Gene_or_gene_product"	"cyclin E	132	140	Gene_or_gene_product"	"gastric carcinomas	162	180	Cancer"	"tissue	187	193	Tissue"	"[{""token"": ""EOGCs"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""CDC4"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - myc"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - jun"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin E"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinomas"", ""start_span"": 162, ""end_span"": 180, ""type"": ""Cancer""}, {""token"": ""tissue"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Tissue""}]"
Several regulatory and signaling molecules governing angiogenesis are of interest, including growth factors ( eg, vascular endothelial growth factor, platelet - derived growth factor, fibroblast growth factor, and epidermal growth factor), receptor tyrosine kinases, and transcription factors such as hypoxia inducible factor, as well as molecules involved in mitogen - activated protein kinase ( MAPK) and phosphoinositide 3 - kinase ( PI3K) signaling.	"vascular endothelial growth factor	114	148	Gene_or_gene_product"	"platelet - derived growth factor	150	182	Gene_or_gene_product"	"fibroblast growth factor	184	208	Gene_or_gene_product"	"epidermal growth factor	214	237	Gene_or_gene_product"	"hypoxia inducible factor	301	325	Gene_or_gene_product"	"mitogen - activated protein kinase	360	394	Gene_or_gene_product"	"MAPK	397	401	Gene_or_gene_product"	"phosphoinositide 3 - kinase	407	434	Gene_or_gene_product"	"PI3K	437	441	Gene_or_gene_product"	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 114, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelet - derived growth factor"", ""start_span"": 150, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblast growth factor"", ""start_span"": 184, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor"", ""start_span"": 214, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxia inducible factor"", ""start_span"": 301, ""end_span"": 325, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 360, ""end_span"": 394, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 397, ""end_span"": 401, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphoinositide 3 - kinase"", ""start_span"": 407, ""end_span"": 434, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 437, ""end_span"": 441, ""type"": ""Gene_or_gene_product""}]"
Multiple proteins involved in metastasis and the cytoskeletal reorganization signal pathway, including Ras, Cdc42, Rac1, RhoA, RhoB, PI3K and p38MAPK, were also inhibited by GA.	"cytoskeletal	49	61	Cellular_component"	"Ras	103	106	Gene_or_gene_product"	"Cdc42	108	113	Gene_or_gene_product"	"Rac1	115	119	Gene_or_gene_product"	"RhoA	121	125	Gene_or_gene_product"	"RhoB	127	131	Gene_or_gene_product"	"PI3K	133	137	Gene_or_gene_product"	"p38MAPK	142	149	Gene_or_gene_product"	"GA	174	176	Chemical"	"[{""token"": ""cytoskeletal"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Cellular_component""}, {""token"": ""Ras"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc42"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rac1"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoB"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38MAPK"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""GA"", ""start_span"": 174, ""end_span"": 176, ""type"": ""Chemical""}]"
The activated PI3K ( phosphoinositide 3 - kinase) / Akt signalling pathway in LNCaP cells contributes to the phosphorylation of PFKFB2 at Ser466 and Ser483, resulting in the constitutive activation of PFK - 2 ( 6 - phosphofructo - 2 - kinase) activity.	"PI3K	14	18	Gene_or_gene_product"	"phosphoinositide 3 - kinase	21	48	Gene_or_gene_product"	"Akt	52	55	Gene_or_gene_product"	"LNCaP cells	78	89	Cell"	"PFKFB2	128	134	Gene_or_gene_product"	"Ser466	138	144	Amino_acid"	"Ser483	149	155	Amino_acid"	"PFK - 2	201	208	Gene_or_gene_product"	"6 - phosphofructo - 2 - kinase	211	241	Gene_or_gene_product"	"[{""token"": ""PI3K"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphoinositide 3 - kinase"", ""start_span"": 21, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""LNCaP cells"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""PFKFB2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ser466"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Amino_acid""}, {""token"": ""Ser483"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Amino_acid""}, {""token"": ""PFK - 2"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""6 - phosphofructo - 2 - kinase"", ""start_span"": 211, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}]"
Taken together, our results suggest that the induction of de novo lipid synthesis by androgen requires the transcriptional up - regulation of HK2 and PFKFB2, and phosphorylation of PFKFB2 generated by the PI3K / Akt signalling pathway to supply the source for lipogenesis from glucose in prostate cancer cells.	"lipid	66	71	Chemical"	"androgen	85	93	Chemical"	"HK2	142	145	Gene_or_gene_product"	"PFKFB2	150	156	Gene_or_gene_product"	"PFKFB2	181	187	Gene_or_gene_product"	"PI3K	205	209	Gene_or_gene_product"	"Akt	212	215	Gene_or_gene_product"	"glucose	277	284	Chemical"	"prostate cancer cells	288	309	Cell"	"[{""token"": ""lipid"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""androgen"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""HK2"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""PFKFB2"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""PFKFB2"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 277, ""end_span"": 284, ""type"": ""Chemical""}, {""token"": ""prostate cancer cells"", ""start_span"": 288, ""end_span"": 309, ""type"": ""Cell""}]"
Thymidylate synthase ( TS) and dihydropyrimidine dehydrogenase ( DPD) are 5 - fluorouracil ( 5 - FU) metabolizing enzymes and are involved in the sensitivity of carcinoma patients to 5 - FU.	"Thymidylate synthase	0	20	Gene_or_gene_product"	"TS	23	25	Gene_or_gene_product"	"dihydropyrimidine dehydrogenase	31	62	Gene_or_gene_product"	"DPD	65	68	Gene_or_gene_product"	"5 - fluorouracil	74	90	Chemical"	"5 - FU	93	99	Chemical"	"carcinoma	161	170	Cancer"	"patients	171	179	Organism"	"5 - FU	183	189	Chemical"	"[{""token"": ""Thymidylate synthase"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""TS"", ""start_span"": 23, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""dihydropyrimidine dehydrogenase"", ""start_span"": 31, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""DPD"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""5 - fluorouracil"", ""start_span"": 74, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""carcinoma"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 171, ""end_span"": 179, ""type"": ""Organism""}, {""token"": ""5 - FU"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Chemical""}]"
The different tumorigenic potential of SV40 in WAP - T and WAP - mutCK1delta / WAP - T tumors was also reflected by a significantly different expression of various genes known to be involved in tumor progression, specifically of those involved in wnt - signaling and DNA repair.	"SV40	39	43	Organism"	"WAP - T	47	54	Gene_or_gene_product"	"WAP	59	62	Gene_or_gene_product"	"mutCK1delta	65	76	Gene_or_gene_product"	"WAP - T	79	86	Gene_or_gene_product"	"tumors	87	93	Cancer"	"tumor	194	199	Cancer"	"wnt	247	250	Gene_or_gene_product"	"DNA	267	270	Cellular_component"	"[{""token"": ""SV40"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""WAP - T"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""mutCK1delta"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP - T"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Cancer""}, {""token"": ""wnt"", ""start_span"": 247, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 267, ""end_span"": 270, ""type"": ""Cellular_component""}]"
From in vivo experiments using new methods such as the rabbit cornea, it is now becoming clear that the growth of a capillary involves an ordered sequence of events that includes lysis of the basement membrane of a parent venule, directional migration of capillary endothelial cells toward the angiogenic stimulus, lumen formation, development of branches, and anastomosis of the tip of one tube with another to form a loop.	"rabbit	55	61	Organism"	"cornea	62	68	Multi"	"capillary	116	125	Tissue"	"basement membrane	192	209	Cellular_component"	"venule	222	228	Multi"	"capillary endothelial cells	255	282	Cell"	"lumen	315	320	Immaterial_anatomical_entity"	"branches	347	355	Tissue"	"tube	391	395	Tissue"	"[{""token"": ""rabbit"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""cornea"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Multi""}, {""token"": ""capillary"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Tissue""}, {""token"": ""basement membrane"", ""start_span"": 192, ""end_span"": 209, ""type"": ""Cellular_component""}, {""token"": ""venule"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Multi""}, {""token"": ""capillary endothelial cells"", ""start_span"": 255, ""end_span"": 282, ""type"": ""Cell""}, {""token"": ""lumen"", ""start_span"": 315, ""end_span"": 320, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""branches"", ""start_span"": 347, ""end_span"": 355, ""type"": ""Tissue""}, {""token"": ""tube"", ""start_span"": 391, ""end_span"": 395, ""type"": ""Tissue""}]"
H4IIEC3 ( H4), a differentiated rat hepatoma line and H5, its dedifferentiated subclone, were investigated as proliferating spheroids and as implanted subcutaneous tumors in juvenile rats.	"H4IIEC3	0	7	Cell"	"H4	10	12	Cell"	"rat	32	35	Organism"	"hepatoma line	36	49	Cell"	"H5	54	56	Cell"	"subclone	79	87	Cell"	"spheroids	124	133	Cell"	"subcutaneous tumors	151	170	Cancer"	"juvenile rats	174	187	Organism"	"[{""token"": ""H4IIEC3"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Cell""}, {""token"": ""H4"", ""start_span"": 10, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Organism""}, {""token"": ""hepatoma line"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""H5"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""subclone"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""subcutaneous tumors"", ""start_span"": 151, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""juvenile rats"", ""start_span"": 174, ""end_span"": 187, ""type"": ""Organism""}]"
Two of the mutations included a G to C substitution at codon 12, and a G to A substitution at codon 18, resulting in a glycine to arginine, and an alanine to threonine change at these amino acids, respectively.	"G	32	33	Chemical"	"C	37	38	Chemical"	"G	71	72	Chemical"	"A	76	77	Chemical"	"glycine	119	126	Amino_acid"	"arginine	130	138	Amino_acid"	"alanine	147	154	Amino_acid"	"threonine	158	167	Amino_acid"	"amino acids	184	195	Amino_acid"	"[{""token"": ""G"", ""start_span"": 32, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""C"", ""start_span"": 37, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""G"", ""start_span"": 71, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""A"", ""start_span"": 76, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""glycine"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Amino_acid""}, {""token"": ""arginine"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Amino_acid""}, {""token"": ""alanine"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Amino_acid""}, {""token"": ""threonine"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Amino_acid""}, {""token"": ""amino acids"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Amino_acid""}]"
Levels of uPA, urokinase - plasminogen activator receptor ( uPAR) and plasminogen activator inhibitor - 1 ( PAI - 1) were measured semiquantitatively in paraffin sections of tumours from 147 patients with NSCLC.	"uPA	10	13	Gene_or_gene_product"	"urokinase - plasminogen activator receptor	15	57	Gene_or_gene_product"	"uPAR	60	64	Gene_or_gene_product"	"plasminogen activator inhibitor - 1	70	105	Gene_or_gene_product"	"PAI - 1	108	115	Gene_or_gene_product"	"sections	162	170	Cancer"	"tumours	174	181	Cancer"	"patients	191	199	Organism"	"NSCLC	205	210	Cancer"	"[{""token"": ""uPA"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""urokinase - plasminogen activator receptor"", ""start_span"": 15, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPAR"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasminogen activator inhibitor - 1"", ""start_span"": 70, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI - 1"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""sections"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 191, ""end_span"": 199, ""type"": ""Organism""}, {""token"": ""NSCLC"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Cancer""}]"
